Unmasking systolic impairment in HFpEF by cardiovascular magnetic resonance derived hemodynamic force assessment: Insights from the HFpEF stress trial

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Soeren Jan Backhaus

Kerckhoff Heart and Thorax Center, Bad Nauheim (Germany)

7 More presentations in this session

Presentation thumbnail

Investigating myocardial energetic deficit across the spectrum of cardiac disease

Doctor A. Henry (St Helier, JE)

Abstract Slides

Presentation thumbnail

Prognostic implications of trabecular complexity measured by fractal analysis in left ventricular noncompaction

Miss A. Romero Valero (Elche, ES)

Abstract Slides

Presentation thumbnail

Hepatic T1-time predicts cardiovascular risk in all-comers referred for cardiovascular magnetic resonance.

Doctor K. Mascherbauer (Vienna, AT)

Abstract Slides

Presentation thumbnail

Ratio between left and right ventricular end-diastolic volumes and outcomes in patients with heart failure and preserved ejection fraction

Doctor A. Aimo (Pisa, IT)

Abstract Slides

Presentation thumbnail

A phase 2a trial investigating ninerafaxstat - a novel cardiac mitotrope for the treatment of diabetic cardiomyopathy (IMPROVE-DiCE)

Doctor M. Hundertmark (Bern, CH)

Abstract Slides

Access the full session

Session thumbnail

CMR in the evaluation of cardiomyopathies and heart failure

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Presentation

Innovative assessments of myocardial function using myocardial strain

Congress Presentation

Mastering the clinical application of biventricular myocardial deformation

Congress Presentation

Magnetic resonance imaging is the way to go for risk assessment

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources